These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 27183571)

  • 1. Structures of Preferred Human IgV Genes-Based Protective Antibodies Identify How Conserved Residues Contact Diverse Antigens and Assign Source of Specificity to CDR3 Loop Variation.
    Bryson S; Thomson CA; Risnes LF; Dasgupta S; Smith K; Schrader JW; Pai EF
    J Immunol; 2016 Jun; 196(11):4723-30. PubMed ID: 27183571
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatic diversity in CDR3 loops allows single V-genes to encode innate immunological memories for multiple pathogens.
    Thomson CA; Little KQ; Reason DC; Schrader JW
    J Immunol; 2011 Feb; 186(4):2291-8. PubMed ID: 21228346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combinatorial library cloning of human antibodies to Streptococcus pneumoniae capsular polysaccharides: variable region primary structures and evidence for somatic mutation of Fab fragments specific for capsular serotypes 6B, 14, and 23F.
    Lucas AH; Moulton KD; Tang VR; Reason DC
    Infect Immun; 2001 Feb; 69(2):853-64. PubMed ID: 11159978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of monovalent fragments derived from a human IgM autoantibody in E. coli. The input of the somatically mutated CDR1/CDR2 and of the CDR3 into antigen binding specificity.
    Jahn S; Roggenbuck D; Niemann B; Ward ES
    Immunobiology; 1995 Aug; 193(5):400-19. PubMed ID: 8522357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of antigenic epitope and antibody gene usage in the human immune response to Streptococcus pneumoniae type 23F capsular polysaccharide.
    Reason DC; Zhou J
    Clin Immunol; 2004 Apr; 111(1):132-6. PubMed ID: 15093562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic hypermutation and diverse immunoglobulin gene usage in the human antibody response to the capsular polysaccharide of Streptococcus pneumoniae Type 6B.
    Zhou J; Lottenbach KR; Barenkamp SJ; Reason DC
    Infect Immun; 2004 Jun; 72(6):3505-14. PubMed ID: 15155658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for a specificity switch and for maintenance of affinity using mutational analysis of a phage-displayed anti-arsonate antibody of Fab heavy chain first complementarity-determining region.
    Wong YW; Gill DS; Parhami-Seren B; Short MK; Sompuram SR; Margolies MN
    J Immunol; 1998 Jun; 160(12):5990-7. PubMed ID: 9637513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Germline V-genes sculpt the binding site of a family of antibodies neutralizing human cytomegalovirus.
    Thomson CA; Bryson S; McLean GR; Creagh AL; Pai EF; Schrader JW
    EMBO J; 2008 Oct; 27(19):2592-602. PubMed ID: 18772881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro antibody maturation. Improvement of a high affinity, neutralizing antibody against IL-1 beta.
    Jackson JR; Sathe G; Rosenberg M; Sweet R
    J Immunol; 1995 Apr; 154(7):3310-9. PubMed ID: 7897213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional mapping of conserved residues located at the VL and VH domain interface of a Fab.
    Chatellier J; Van Regenmortel MH; Vernet T; Altschuh D
    J Mol Biol; 1996 Nov; 264(1):1-6. PubMed ID: 8950262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural determinants of the human idiotype HibId-1.
    Reason DC; O'Connor AP; Lucas AH
    J Mol Recognit; 2001; 14(6):393-400. PubMed ID: 11757072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autoreactivity of primary human immunoglobulins ancestral to hypermutated human antibodies that neutralize HCMV.
    McLean GR; Cho CW; Schrader JW
    Mol Immunol; 2006 May; 43(12):2012-22. PubMed ID: 16423397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of human anti-heat shock protein 60 monoclonal autoantibody Fab fragments in atherosclerosis: genetic and functional analysis.
    Jang EJ; Jung KY; Hwang E; Jang YJ
    Mol Immunol; 2013 Jul; 54(3-4):338-46. PubMed ID: 23357787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured Fab in complex with antigen.
    Chen Y; Wiesmann C; Fuh G; Li B; Christinger HW; McKay P; de Vos AM; Lowman HB
    J Mol Biol; 1999 Nov; 293(4):865-81. PubMed ID: 10543973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineering a humanized bispecific F(ab')2 fragment for improved binding to T cells.
    Rodrigues ML; Shalaby MR; Werther W; Presta L; Carter P
    Int J Cancer Suppl; 1992; 7():45-50. PubMed ID: 1428403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three-dimensional structure of an Fab-peptide complex: structural basis of HIV-1 protease inhibition by a monoclonal antibody.
    Lescar J; Stouracova R; Riottot MM; Chitarra V; Brynda J; Fabry M; Horejsi M; Sedlacek J; Bentley GA
    J Mol Biol; 1997 Apr; 267(5):1207-22. PubMed ID: 9150407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Three-dimensional structure of the Fab fragment of a neutralizing antibody to human rhinovirus serotype 2.
    Tormo J; Stadler E; Skern T; Auer H; Kanzler O; Betzel C; Blaas D; Fita I
    Protein Sci; 1992 Sep; 1(9):1154-61. PubMed ID: 1338980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent.
    Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR
    J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of phage surface expression to analyze regions of human V4-34(VH4-21)-encoded IgG autoantibody required for recognition of DNA: no involvement of the 9G4 idiotope.
    Mockridge CI; Chapman CJ; Spellerberg MB; Isenberg DA; Stevenson FK
    J Immunol; 1996 Sep; 157(6):2449-54. PubMed ID: 8805644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on interaction kinetics of mutations at the VH-VL interface of Fabs depend on the structural context.
    Khalifa MB; Weidenhaupt M; Choulier L; Chatellier J; Rauffer-Bruyère N; Altschuh D; Vernet T
    J Mol Recognit; 2000; 13(3):127-39. PubMed ID: 10867708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.